SYNKROSCAFF
A Tissue Engineered Non-Glutaraldehyde Treated Bovine Pericardial Patch
Synkromax Biotech Pvt Ltd, established in 2009, is headquartered in Porur, Chennai, India. The company specializes in the manufacturing of enzymes for various industries, including textile, leather, food, feed, tea, pharma, detergent, pulp & paper, brewery, and distillery.
Key Areas of Operation:
Enzymes: Synkromax produces a wide range of enzymes tailored for different industrial applications.
Textile and Leather Auxiliaries: The company manufactures auxiliaries to support the textile and leather industries.
Agri Products: This includes plant growth promoters and super spreading agents.
Facilities and Presence:
Application Laboratories: Located in Ranipet and Kanpur for leather, and in Chennai for textiles.
Branch Office: Situated in Bangalore.
Manufacturing Facility: Located in Puducherry for leather auxiliaries.
Warehouse: Located in Bhiwandi, Maharashtra, for leather and textile products.
Research and Development:
Synkromax boasts a state-of-the-art Technology Development Centre, providing R&D facilities to research scholars, companies, and institutions. The center focuses on developing biotechnology-based innovative products and processes for pollution abatement and achieving a greener environment.
Vision and Mission:
Synkromax is dedicated to developing biotechnology-based innovative products and process R&D for pollution abatement and achieving a greener environment. The company has a team of qualified and experienced personnel for quality assurance, assay development, and validation of industrial and specialty enzymes.
SynkroScaff is a tissue-engineered bovine pericardial patch developed by Synkromax Biotech Pvt Ltd in collaboration with IIT Madras. This innovative product is designed for critical cardiovascular patients and has several unique features:
Key Features:
Tissue-Engineered: SynkroScaff is made from bovine pericardial tissue that has been engineered to be completely acellularized. This means it does not contain any cells, reducing the risk of immune rejection.
Non-Glutaraldehyde Treated: Unlike traditional patches, SynkroScaff is not treated with glutaraldehyde, which reduces the risk of long-term calcification and thrombogenicity (formation of blood clots).
Regenerative Properties: The patch has inborn properties of regeneration and integration within the body, promoting natural healing and reducing the need for additional surgeries.
Biocompatibility: The use of biomaterial ensures that the patch is biocompatible, minimizing the risk of adverse reactions.
Applications:
Cardiovascular Surgery: SynkroScaff is used for anatomical correction of the heart and its blood vessels in various cardiovascular and other surgical practices.
Global Demand: The technology has a global demand and is being commercially exploited by Synkromax Biotech.
Development and Impact:
Indigenous Technology: Developed indigenously in India, SynkroScaff eliminates the country's dependence on imported surgical patches.
Research and Innovation: The product emerged from doctoral research at IIT Madras and has been recognized for its innovative approach to processing xenogeneic tissue for human use.
SynkroScaff represents a significant advancement in the field of surgical patches, offering a safer and more effective solution for patients undergoing cardiovascular surgeries